Raras
Buscar doenças, sintomas, genes...
Hemorragia alveolar difusa
ORPHA:90060CID-10 · R04.8CID-11 · MD23DOENÇA RARA

Distúrbio respiratório caracterizado por sangramento difuso nos espaços alveolares que se originam da microvasculatura pulmonar, incluindo os capilares alveolares, arteríolas e vênulas. Os pacientes apresentam tosse, dispneia, dor torácica, febre, anemia e hemoptise.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Distúrbio respiratório caracterizado por sangramento difuso nos espaços alveolares que se originam da microvasculatura pulmonar, incluindo os capilares alveolares, arteríolas e vênulas. Os pacientes apresentam tosse, dispneia, dor torácica, febre, anemia e hemoptise.

Pesquisas ativas
1 ensaio
1 total registrados no ClinicalTrials.gov
Publicações científicas
1.360 artigos
Último publicado: 2026 Apr 17

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
1.0
Europe
Início
Adolescent
+ adult, childhood, elderly, infancy
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: R04.8
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫁
Pulmão
9 sintomas
🩸
Sangue
4 sintomas
🫘
Rins
2 sintomas
👂
Ouvidos
1 sintomas
🧬
Pele e cabelo
1 sintomas
🛡️
Imunológico
1 sintomas

+ 13 sintomas em outras categorias

Características mais comuns

90%prev.
Infiltrados pulmonares
Muito frequente (99-80%)
55%prev.
Hemoptise
Frequente (79-30%)
55%prev.
Autoimunidade
Frequente (79-30%)
55%prev.
Opacificação em vidro fosco na TC de alta resolução pulmonar
Frequente (79-30%)
55%prev.
Perda de peso
Frequente (79-30%)
55%prev.
Taxa de sedimentação de eritrócitos elevada
Frequente (79-30%)
34sintomas
Muito frequente (1)
Frequente (8)
Ocasional (20)
Muito raro (5)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 34 características clínicas mais associadas, ordenadas por frequência.

Infiltrados pulmonaresPulmonary infiltrates
Muito frequente (99-80%)90%
HemoptiseHemoptysis
Frequente (79-30%)55%
AutoimunidadeAutoimmunity
Frequente (79-30%)55%
Opacificação em vidro fosco na TC de alta resolução pulmonarGround-glass opacification on pulmonary HRCT
Frequente (79-30%)55%
Perda de pesoWeight loss
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.360PubMed
Últimos 10 anos200publicações
Pico202594 papers
Linha do tempo
2026Hoje · 2026🧪 2021Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Hemorragia alveolar difusa

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
874 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 874

#1

A Bloody Cough and Clouded Lungs: Uncovering a Systemic Culprit in an Adolescent.

Pediatrics2026 Mar 01

Hemoptysis secondary to diffuse alveolar hemorrhage (DAH) is uncommon in children. When it does occur, extensive investigations are often required to determine the underlying cause. We present a unique case of a 17-year-old previously healthy male adolescent with a history of allergic rhinitis, who initially presented with pneumonia in the setting of influenza A. He subsequently developed DAH, prompting further diagnostic evaluations that ultimately revealed a rare condition with long-term morbidity.

#2

Incidence and Impact of Endothelial Dysfunction Events and Veno-Occlusive Disease in Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide: A Retrospective Analysis From the Argentinian Group of Marrow Transplant and Cellular Therapy (GATMO-TC).

Transplantation and cellular therapy2026 Jan 09

Endothelial dysfunction events (EDE) and veno-occlusive disease (VOD) are clinically relevant early complications after hematopoietic stem cell transplantation (HSCT). Data in haploidentical HSCT (HaploSCT) using post-transplant cyclophosphamide (PTCy) are limited in Latin American settings. We conducted a retrospective multicenter study including 310 consecutive adult patients (≥18 years) undergoing unmanipulated HaploSCT with PTCy between 2015 and 2022 across 8 centers in Argentina. EDE was defined as a composite endpoint including VOD, transplant-associated microangiopathy (TMA), renal dysfunction, diffuse alveolar hemorrhage (DAH), and posterior reversible encephalopathy syndrome (PRES); acute GvHD (aGvHD) was analyzed separately (MAGIC criteria). VOD cases were re-adjudicated using EBMT criteria as the standard. Disease risk was categorized using the disease risk index (DRI). All patients received ursodeoxycholic acid prophylaxis and PTCy-based GvHD prophylaxis. Cumulative incidence functions were estimated with competing risks and compared with Gray's test; Fine-Gray models were used for multivariable analyses. Overall survival (OS) was analyzed by Kaplan-Meier and log-rank testing (2-sided P < .05). Median age was 42 years (range 18 to 77) and median follow-up was 37.7 months. Most patients received myeloablative conditioning (75.2%); conditioning backbone was busulfan-based in 54.0%, TBI-based in 34.6%, and melphalan/other in 11.4%. At 1 year, cumulative incidence of EDE (composite including VOD) was 5.5% (95% CI 3.0 to 8.0), with median time to first EDE 30.5 days (IQR 16.3 to 36.8). Among 18 EDE cases, phenotypes were VOD (n = 9; 50.0%), transplant-associated microangiopathy (TMA) (n = 5; 27.8%), renal dysfunction (n = 2; 11.1%), diffuse alveolar hemorrhage (DAH) (n = 1; 5.6%), and posterior reversible encephalopathy syndrome (PRES) (n = 1; 5.6%). Patients aged ≤25 years had higher EDE incidence than >25 years (11.5% [95% CI 3.9 to 19.0] versus 3.8% [95% CI 1.3 to 6.2]; Gray P = .021). In multivariable Fine-Gray regression, age ≤25 years was the only independent predictor of EDE (SHR 4.26; 95% CI 1.42 to 12.74; P = .01). By day 100, cumulative incidence of grade II to IV and grade III to IV aGvHD was 29.8% (95% CI 24.2 to 35.4) and 9.0% (95% CI 5.3 to 12.8), respectively; EDE was associated with higher aGvHD incidence (SHR 3.14; 95% CI 1.47 to 6.68; P = .003). Median time to VOD diagnosis was 25 days (range 8 to 57); 44.4% were classical (≤21 days) and 55.6% late-onset, with severe VOD comprising 55.6%. Three-month VOD incidence was higher in patients ≤25 years (8.6% [95% CI 2.0 to 15.3]) versus >25 years (1.2% [95% CI 0.0 to 2.7]; Gray P = .001). OS was worse in patients with EDE (log-rank P = .014): median OS 7.9 months (95% CI 2.3 to 15.5) versus 23.4 months (95% CI 16.3 to 29.6), and 2-year OS 25.0% (95% CI 6.7 to 49.1) versus 49.6% (95% CI 43.2 to 55.7). In this multicenter adult HaploSCT-PTCy cohort, EDE and VOD were infrequent but associated with substantially inferior OS. Age ≤25 years consistently identified a higher-risk subgroup for EDE and VOD, supporting intensified surveillance and early recognition strategies in this platform.

#3

Pulmonary hemorrhage as a first manifestation of Sjögren's disease in a young male adult.

Folia medica2026 Feb 26

Sjögren's syndrome (SS) is a chronic autoimmune disorder primarily affecting exocrine glands, characterized by dry mouth (xerostomia) and dry eyes (keratoconjunctivitis sicca). However, systemic manifestations, including pulmonary complications, are increasingly recognized. Diffuse alveolar hemorrhage (DAH) is a rare but life-threatening presentation of SS, typically associated with vasculitis or coagulation abnormalities. We report the case of a 19-year-old male presenting with dyspnea and hemoptysis, later diagnosed with primary Sjögren's syndrome (pSS). Initial clinical assessment revealed respiratory failure with low blood oxygen levels (hypoxemia), bilateral ground-glass opacities on chest computed tomography (CT), and iron-storing macrophages (hemosiderin-laden) in bronchoalveolar lavage fluid, consistent with DAH. Subsequent autoimmune serology confirmed positivity for anti-Ro/Sjögren's-syndrome-related antigen A autoantibodies (SSA) and anti-La/Sjögren's-syndrome-related antigen B autoantibodies (SSB), while other autoimmune markers, including anti-neutrophil cytoplasmic antibodies (ANCA), were negative. Labial salivary gland biopsy demonstrated focal lymphocytic sialadenitis, confirming pSS according to European League Against Rheumatism (EULAR) criteria. Treatment involved high-dose corticosteroids, leading to complete resolution of symptoms and significant improvement in imaging results. The patient remained stable at follow-up. DAH should be considered a potential presentation of pSS, even in the absence of classical symptoms. Increased awareness of this rare complication can facilitate early diagnosis and improve outcomes.

#4

Therapeutic Evolution and Outcomes in EGPA Complicated by Diffuse Alveolar Hemorrhage: case-based review.

Modern rheumatology case reports2026 Mar 25

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic vasculitis characterized by asthma, eosinophilia, and multi-organ involvement. Diffuse alveolar hemorrhage (DAH) is an uncommon but life-threatening pulmonary complication in EGPA. We report a 49-year-old previously healthy woman who presented initially with asthma-like symptoms and later developed fever, hemoptysis, cutaneous purpura, and periorbital edema. Laboratory evaluation revealed marked eosinophilia, anemia, elevated inflammatory markers, and strongly positive MPO-ANCA. Bronchoalveolar lavage fluid (BALF) was hemorrhagic and contained hemosiderin-laden macrophages, indicating DAH. Broad-spectrum antibiotics were empirically initiated but discontinued after metagenomic next-generation sequencing (mNGS) of BALF excluded infection. Bone marrow biopsy showed eosinophilic hyperplasia without clonal mutations. A diagnosis of MPO-ANCA positive EGPA with DAH was established. The patient received pulse methylprednisolone, prednisone, intravenous immunoglobulin, mepolizumab, and rituximab. Clinical symptoms improved rapidly, and radiological signs of alveolar hemorrhage nearly resolved within days. Our case illustrates that integration of rituximab and mepolizumab with corticosteroids can achieve rapid remission and steroid sparing in EGPA-DAH. While evidence remains limited to case reports and small series, targeted biologics may fundamentally improve outcomes in this high-risk subset. Prospective studies are warranted to define optimal treatment strategies.

#5

Diffuse alveolar hemorrhage in systemic lupus erythematosus during the COVID-19 era-a retrospective analysis with mechanistic investigation.

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi2026 Mar 12

Viral infection plays an important role in driving activity of autoimmune diseases. Preceding SARS-CoV-2 infection has been observed to trigger disease flares in systemic lupus erythematosus (SLE). Besides cytomegalovirus, SARS-CoV-2 can induce pulmonary capillaritis to develop diffuse alveolar hemorrhage (DAH), a respiratory emergency of SLE. Owing to lack of comprehensive studies for SARS-CoV-2-triggered DAH in SLE, we conducted a monocentric analysis with mechanistic investigation. Hospitalized SLE patients were retrospectively analyzed for the DAH manifestation in the COVID-19 era since December 2019, focusing on those with preceding SARS-CoV-2 infection. Peripheral blood (PB) and lung tissues samples and immune/alveolus cell lines were used for mechanistic research. Twenty-five DAH episodes were identified in 21 SLE patients (3% occurrence), all in disease flares with high activity scores. During the domestic omicron variant outbreak, 7 patients (33%) had preceding SARS-CoV-2 infection, 3 to 7 weeks earlier to the onset of DAH, while they had elevated IL-6, nitro-oxidative stress- and cell death-associated molecules levels in PB and lung tissues with enhanced apoptosis formation. IL-6-stimulated alveolus/immune cells exhibited a dose-dependent increase in nitro-oxidative stress- and cell death-associated molecules levels, up-regulated p38MAPK/NF-κB-p65 phosphorylation, raised ROS expression and enhanced apoptosis formation. These findings implicated cell death induced by IL-6-activated nitro-oxidative stress to generate circulating immune complexes with pulmonary deposition as the mechanism for DAH preceded by SARS-CoV-2 infection in SLE. The DAH manifestation preceded by SARS-CoV-2 infection is observed in SLE with disease flares, requiring careful monitor and management of COVID-19 in such patients.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC755 artigos no totalmostrando 200

2026

Pulmonary hemorrhage as a first manifestation of Sjögren's disease in a young male adult.

Folia medica
2026

Therapeutic Evolution and Outcomes in EGPA Complicated by Diffuse Alveolar Hemorrhage: case-based review.

Modern rheumatology case reports
2026

Diffuse alveolar hemorrhage in systemic lupus erythematosus during the COVID-19 era-a retrospective analysis with mechanistic investigation.

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
2026

Sevoflurane-Associated Diffuse Alveolar Hemorrhage-A Rare Pediatric Presentation.

Pediatric pulmonology
2026

[Clinical, imaging, and pathological features of diffuse alveolar filling diseases].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2026

Emergence of a novel reassorted high pathogenicity avian influenza A(H5N2) virus associated with severe pneumonia in a young adult.

Scientific reports
2026

Early VV-ECMO enabling immunosuppressive therapy in severe diffuse alveolar hemorrhage due to ANCA-associated vasculitis.

Respiratory medicine case reports
2026

Anti-Myeloperoxidase (MPO)-Positive Granulomatosis With Polyangiitis Presenting With Pulmonary and Cutaneous Vasculitic Flares in End-Stage Renal Disease: A Diagnostic and Therapeutic Challenge.

Cureus
2026

Therapeutic Dilemmas in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Diffuse Alveolar Hemorrhage and Venous Thromboembolism.

ACR open rheumatology
2026

MiniBAL as a Diagnostic Alternative in Alveolar Hemorrhage in a Critically Ill Pediatric Patient.

Pediatric pulmonology
2026

Clinical, radiological and laboratory features and outcomes of diffuse alveolar hemorrhage.

Scientific reports
2026

Catastrophic Antiphospholipid Syndrome: A Rare but Life-Threatening Thrombotic Storm-A Case Report and Literature Review.

Case reports in rheumatology
2026

Management of CMV Pneumonia, DAH, and BOS Following HSCT in a Child with β-Thalassemia: A Case Report.

Journal of inflammation research
2026

Surgical Pathology of Diffuse Parenchymal Lung Disease in Adults With IgA Vasculitis or IgA Nephropathy.

The American journal of surgical pathology
2026

Diffuse alveolar hemorrhage in antiphospholipid syndrome: Clinical presentation and prognosis.

Respiratory medicine
2026

Plasma exchange for severe alveolar hemorrhage in ANCA-associated vasculitis: emulation of a target trial.

American journal of respiratory and critical care medicine
2026

The role of arterial embolization in pediatric Idiopathic Pulmonary Hemosiderosis: a case report and literature review.

Respiratory medicine case reports
2026

Local Intrapulmonary Hemostatic Therapies for Pediatric Pulmonary Hemorrhage: A Systematic Review and Meta-Analysis.

Cureus
2026

Pulmonary manifestations of granulomatosis with polyangiitis and microscopic polyangiitis.

Seminars in arthritis and rheumatism
2026

Late post-transplant recurrence of an anti-myeloperoxydase antibody-associated vasculitis in a former double-positive patient: a case report.

Frontiers in immunology
2026

A Bloody Cough and Clouded Lungs: Uncovering a Systemic Culprit in an Adolescent.

Pediatrics
2026

From Aortitis to Sweet's: The Immune Spectrum of G-CSF Adverse Events.

Seminars in arthritis and rheumatism
2026

Unilateral Diffuse Alveolar Hemorrhage in a Polysubstance User: A Case Report.

Cureus
2026

CD20 monoclonal antibody‑rituximab for the treatment of diffuse alveolar hemorrhage in children (Review).

Molecular medicine reports
2026

Liraglutide prevents lupus-associated diffuse alveolar hemorrhage via inhibiting lymphocyte infiltration and promoting macrophage M2 polarization.

Journal of translational autoimmunity
2026

Pyrroloquinoline quinone ameliorates inflammatory responses by modulating macrophage polarization in murine models of SLE and lupus-associated diffuse alveolar hemorrhage.

International immunopharmacology
2026

A fatal case of ANCA-associated vasculitis resulting in multiple organ failure: Case report and literature review.

Medicine
2026

Recurrent diffuse alveolar hemorrhage in Immunoglobulin A vasculitis.

Respiratory medicine case reports
2025

Relapsing Blastic Plasmacytoid Dendritic Cell Neoplasm With Neurologic Involvement.

Cureus
2026

Use of narsoplimab for eculizumab-refractory adult transplant-associated thrombotic microangiopathy (TA-TMA).

Annals of hematology
2026

Efficacy of anifrolumab in recurrent diffuse alveolar hemorrhage associated with systemic lupus erythematosus.

Medicina clinica
2025

Childhood Sjögren's Disease: A Literature Review of an Underrecognized Autoimmune Entity in Pediatric Rheumatology.

Cureus
2026

Incidence and Impact of Endothelial Dysfunction Events and Veno-Occlusive Disease in Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide: A Retrospective Analysis From the Argentinian Group of Marrow Transplant and Cellular Therapy (GATMO-TC).

Transplantation and cellular therapy
2026

Refining the Radiologic Recognition of Pulmonary Alveolar Proteinosis: A Crazy-Paving Pattern Approach.

Seminars in roentgenology
2026

Strongyloides stercoralis infection: A rare cause of diffuse alveolar hemorrhage.

Medicina clinica
2026

Lung-limited granulomatosis with polyangiitis and the importance of early treatment: a case report.

Annals of medicine and surgery (2012)
2025

[Clinical characteristics and prognosis of primary immune thrombocytopenia complicated with diffuse alveolar hemorrhage].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
2025

Simultaneous Diffuse Alveolar Hemorrhage and Acute Myocarditis in an Immunocompetent Adult with a Human Metapneumovirus Infection: A Case Report.

Internal medicine (Tokyo, Japan)
2025

Clinical features and pulmonary infections of diffuse alveolar hemorrhage in rheumatic disease patients.

PloS one
2025

Beyond Infection and Lupus Flare: MPO-ANCA Microscopic Polyangiitis Causing Diffuse Alveolar Hemorrhage in a Patient With Systemic Lupus Erythematosus.

Clinical case reports
2025

Outcome predictors of systemic lupus erythematosus requiring admission to the intensive care unit.

World journal of critical care medicine
2025

Back to the Diving Board: A Rare Cause of Hemoptysis in a Healthy Female Athlete.

Case reports in pulmonology
2025

Transcatheter Edge-to-Edge Repair for Severe Acute Mitral Valve Regurgitation in Diffuse Alveolar Hemorrhage: A Case Report.

The American journal of case reports
2025

Tirofiban-Induced Diffuse Alveolar Hemorrhage in a Patient With Acute Myocardial Infarction Following Primary Percutaneous Coronary Intervention: A Case Report.

Cureus
2025

[Chemotherapy-free induction therapy for a critically ill pregnant woman with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case report and literature review].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
2025

Diagnosis and treatment of systemic vasculitis: Case report and literature review.

Medicine
2025

Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory Domains.

Current rheumatology reports
2026

Exosomal miR-132-3p derived from M1 macrophages mediates diffuse alveolar haemorrhage in systemic lupus erythematosus.

Rheumatology (Oxford, England)
2025

Primary Antiphospholipid Syndrome Presenting With Life-Threatening Diffuse Alveolar Hemorrhage.

Cureus
2025

Anticoagulation-free VV-ECMO for a child with intractable pulmonary hemorrhage: A case report.

Perfusion
2025

Diffuse Alveolar Hemorrhage.

Seminars in respiratory and critical care medicine
2025

Cocaine- and Levamisole-Induced Vasculitis (CLIV).

Cureus
2025

Noninfectious Severe Pulmonary Complications in Immunocompromised Critically Ill Patients.

Seminars in respiratory and critical care medicine
2026

Diffuse alveolar hemorrhage induced by epileptic seizure.

Epileptic disorders : international epilepsy journal with videotape
2025

Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxis.

Annals of hematology
2025

Malignancies Presenting with Alveolar Infiltrates: Diagnostic Pitfalls, Radiologic Clues, and Clinical Patterns.

Seminars in respiratory and critical care medicine
2025

Proteinase 3-Antineutrophil Cytoplasmic Antibody (PR3-ANCA)-Associated Vasculitis: A Case Report.

Cureus
2025

Management and outcome of immune-mediated diffuse alveolar hemorrhage: a single centre case series.

ARP rheumatology
2025

Salvage extracorporeal membrane oxygenation in severe pulmonary haemorrhage: A single-center retrospective observational study.

Perfusion
2025

Abatacept improves posttransplant survival and reduces endothelial injury syndromes in β-thalassemia major.

Blood advances
2025

Diffuse Alveolar Hemorrhage Leading to Respiratory Failure in Mixed Phenotype Acute Leukemia: A Fatal Pulmonary Complication.

Cureus
2025

Diffuse Alveolar Hemorrhage as a Rare Initial Presentation of Systemic Lupus Erythematosus in Early Pregnancy: A Case Report.

Clinical case reports
2025

Case Report: virus infection-induced exacerbations of lung injury and fibrosis in children with diffuse alveolar hemorrhage: report of three cases.

Frontiers in pediatrics
2025

Characteristics of Systemic Lupus Erythematosus Patients with Diffuse Alveolar Hemorrhage: Clinical Features and Outcomes from a Single-Center Experience.

Journal of clinical medicine
2025

[Pulmonary manifestations of ANCA-associated vasculitis in imaging].

Radiologie (Heidelberg, Germany)
2025

A comparative analysis of clinical phenotypes and outcomes in childhood interstitial lung disease due to surfactant dysfunction disorders: focusing on mutations in SFTPC, ABCA3, and NKX2-1 genes.

Italian journal of pediatrics
2025

Laminaria tent use for dilation, extraction, and curettage leading to septic shock: a case report.

Journal of medical case reports
2025

A rare cause of diffuse alveolar hemorrhage in a pediatric patient: thigh localization of INI1-deficient epithelioid sarcoma.

Orphanet journal of rare diseases
2025

Respiratory infection induced episode of alveolar hemorrhage (RIIEAH) in the pediatric diffuse alveolar hemorrhage: a retrospective single-center study.

BMC pediatrics
2025

Granulomatosis With Polyangiitis Complicated by Diffuse Alveolar Hemorrhage and Mitral Valve Chordal Rupture: An Uncommon Cardiopulmonary Manifestation.

Cureus
2025

Interstitial Lung Disease as a Herald of P-ANCA Vasculitis: A Case of Evolving Multisystem Disease.

Cureus
2025

When the Unexpected Happens: Diffuse Alveolar Hemorrhage in Negative-Pressure Pulmonary Edema.

Cureus
2025

Hydralazine-Induced ANCA-Associated Vasculitis With Lupus Nephritis Features and a Unique Antibody Profile.

Journal of community hospital internal medicine perspectives
2025

Management of Anticoagulation in Antiphospholipid Syndrome and Systemic Lupus Erythematosus With Concurrent Thrombosis and Hemorrhage.

Cureus
2025

Axl receptor tyrosine kinase inhibition ameliorates murine lupus diffuse alveolar hemorrhage by regulating macrophage activation.

International immunopharmacology
2025

Idiopathic pulmonary hemosiderosis: A pediatric case report.

Respiratory medicine case reports
2025

Diffuse alveolar Hemorrhage as the initial presentation of systemic lupus erythematosus in a 57-year-old patient: a case report.

Oxford medical case reports
2026

Diffuse Alveolar Hemorrhage Caused by Metastatic Breast Cancer.

Internal medicine (Tokyo, Japan)
2025

Rare presentation of pulmonary tuberculosis as diffuse alveolar hemorrhage.

The Indian journal of tuberculosis
2025

High Prevalence of Abnormal Baseline Lung Function in Pediatric and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Report from the TRANSPIRE Study.

Pediatric blood &amp; cancer
2025

Diffuse alveolar hemorrhage syndrome in children: Primary immunodeficiency diseases and implications for clinical management.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2025

Synergistic Drug-Induced Diffuse Alveolar Hemorrhage in a Polysubstance User: A Case of Inhaled Cocaine and Fentanyl Toxicity.

Cureus
2025

Emphysema: an ignored radiologic sign of diffuse alveolar hemorrhage.

BMC pediatrics
2025

Diffuse Alveolar Hemorrhage in ANCA-Associated Vasculitis.

The New England journal of medicine
2025

Clinical Impact of Vaping.

Toxics
2025

Diffuse Alveolar Hemorrhage as the First Presentation of Systemic Lupus Erythematosus: A Case Report.

The American journal of case reports
2025

Recurrence of Diffuse Alveolar Hemorrhage via Postoperative Thrombotic Valve Formation after Mitral Valve Bioprosthetic Replacement.

Cureus
2025

Successful management of severe pulmonary form of leptospirosis with VV-ECMO, prone ventilation, and bronchoalveolar lavage: two case reports.

Frontiers in medicine
2025

Diffuse alveolar hemorrhage as a clinical manifestation of cardiac angiosarcoma in a pregnant woman with antiphospholipid syndrome: case report and review of the literature.

Ecancermedicalscience
2025

Angiosarcoma Beneath a Bleeding Aneurysmal Veil.

JACC. Case reports
2025

Double Trouble: A Case Report of Hydralazine-Induced Vasculitis and Lupus.

Cureus
2025

Connective Tissue Disorder-Induced Diffuse Alveolar Hemorrhage: A Comprehensive Review with an Emphasis on Airway and Respiratory Management.

Life (Basel, Switzerland)
2025

Corticosteroid Therapy for Diffuse Alveolar Hemorrhage with Respiratory Failure in Hematologic Malignancies: A Retrospective Cohort Study.

Therapeutics and clinical risk management
2025

Role of Extracorporeal Membrane Oxygenation for the Treatment of Diffuse Alveolar Hemorrhage in Granulomatosis With Polyangiitis: A Case Report.

International journal of rheumatic diseases
2025

Therapeutics controversies in antineutrophilic cytoplasmic antibody-associated vasculitis.

Clinical and experimental nephrology
2025

Antiphospholipid Syndrome: An Antibody-Mediated Disease With Emerging Therapeutic Opportunities.

Arthritis &amp; rheumatology (Hoboken, N.J.)
2025

Dasatinib-related diffuse alveolar hemorrhage in de novo blast phase chronic myeloid leukemia: a case report.

Fukushima journal of medical science
2025

Strongyloides Stercoralis Infection Mimicking Relapse of ANCA Vasculitis.

Indian journal of nephrology
2025

Through the Haze of Hemorrhage: Unraveling Leptospirosis With Diffuse Alveolar Hemorrhage.

Cureus
2025

Survey on Plasmapheresis Practices in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis: Insights From Two Clinical Case Studies.

Kidney international reports
2025

Oxaliplatin-induced diffuse alveolar hemorrhage: A case report.

World journal of clinical oncology
2025

A Case of Pulmonary Hemorrhage, Supratherapeutic International Normalized Ratio (INR), and Anti-neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: Unmasking a Potential Link to Tirzepatide.

Cureus
2025

Efficacy and Safety of Rituximab in Antiglomerular Basement Membrane Disease.

Kidney international reports
2025

Isolated pulmonary injury following electric shock: a case report and literature review.

Annals of medicine and surgery (2012)
2025

Multi-organ Involvement in Catastrophic Antiphospholipid Syndrome: A Challenging Case with a Fatal Outcome.

European journal of rheumatology
2025

[Case report: 38-year-old male with hemoptysis, jaundice and acute kidney injury].

Pneumologie (Stuttgart, Germany)
2025

Intratracheal Candida administration induced lung dysbiosis, activated neutrophils, and worsened lung hemorrhage in pristane-induced lupus mice.

Scientific reports
2025

Highlights from the breakout session: management of special situations in systemic vasculitis.

Rheumatology (Oxford, England)
2025

A Rare Cause of Diffuse Alveolar Hemorrhage in Children: COPA Syndrome.

Pediatric pulmonology
2025

Anti-Glomerular Basement Membrane Antibody Disease: Clinicopathologic Profile and Outcomes.

Indian journal of nephrology
2025

Diffuse Alveolar Hemorrhage Associated with Herbal Medicine: A Case Series and Literature Review.

Internal medicine (Tokyo, Japan)
2025

Risk and triggering factors for diffuse alveolar hemorrhage in primary antiphospholipid syndrome. An observational follow-up study and a systematic review of the literature.

Seminars in arthritis and rheumatism
2025

Diffuse Alveolar Hemorrhage as a Complication of Severe Bronchopulmonary Dysplasia: A Case Report.

Archivos de bronconeumologia
2025

ANCA-associated vasculitis and the impact of diffuse alveolar hemorrhage in elderly patients: a retrospective cohort study.

Rheumatology international
2025

Management dilemma of anti-GBM disease and p-ANCA-associated vasculitis with necrotizing skin lesions in a pediatric patient.

Pediatric nephrology (Berlin, Germany)
2024

Diffuse Alveolar Hemorrhage Linked to Hydralazine.

Journal of Brown hospital medicine
2025

[Recent Advances in Diagnosis and Treatment of Diffuse Alveolar Hemorrhage after Hematopoietic Stem Cell Transplantation --Review].

Zhongguo shi yan xue ye xue za zhi
2025

Refractory Idiopathic Hypereosinophilic Syndrome Presenting with Myocarditis and Responding to Imatinib: A Case Report.

Saudi journal of medicine &amp; medical sciences
2025

IgA Vasculitis Presenting as Pulmonary-Renal Syndrome.

Cureus
2025

Unvaccinated and Unprepared: A COVID-19 Saga of Diffuse Alveolar Hemorrhage.

Cureus
2024

Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort study.

Frontiers in immunology
2025

Diffuse Alveolar Hemorrhage Due to Cannabis Inhalation.

Cureus
2024

Altered lipid homeostasis and autophagy precipitate diffuse alveolar hemorrhage in murine lupus.

Autophagy reports
2025

Diffuse Alveolar Hemorrhage Associated With Anti-PL-7 Antisynthetase Syndrome: A Case Report.

Case reports in pulmonology
2025

Imaging of Pulmonary Vasculitis.

Radiologic clinics of North America
2025

Pathology of Pulmonary Vascular Disease with Radiologic Correlation.

Radiologic clinics of North America
2025

A Rare Sequela of Untreated Streptococcus Pharyngitis: A Case Report.

The Laryngoscope
2025

The role of myocardial bridge of the left anterior descending artery in a sudden death of a ketamine and cannabis user. Addressing the uncertainties on the cause of death in a forensic pathologist's casework.

Legal medicine (Tokyo, Japan)
2024

The Importance of Clinical History in the Etiological Diagnosis of Diffuse Alveolar Hemorrhage Associated With Improper Adrenaline Use.

Cureus
2024

Diffuse Alveolar Hemorrhage Due to Macrolide-Refractory Mycoplasma pneumoniae Diagnosed by FilmArray Analysis of Bronchoalveolar Lavage Fluid.

Cureus
2024

Atypical Adult-Onset IgA Vasculitis With Extremely Rare Complications Including Diffuse Alveolar Hemorrhage, Heart Failure, and Stroke.

Cureus
2024

Distribution of Airway Findings in ANCA-Associated Vasculitis: A 20-Year Observational Analysis.

Diagnostics (Basel, Switzerland)
2025

Comprehensive characteristics of pulmonary antineutrophil cytoplasmic antibody-associated vasculitis and the development of a predictive nomogram for mortality.

International immunopharmacology
2025

A Distinctive Encounter With Diffuse Alveolar Hemorrhage in Granulomatosis With Polyangiitis and Pneumonia.

Clinical case reports
2024

ST elevation myocardial infarction as presenting feature of acute myeloid leukemia.

Medical journal, Armed Forces India
2024

Diffuse Alveolar Hemorrhage as a Life-Threatening Complication of Systemic Lupus Erythematosus: A Case Report.

Cureus
2025

Thoracic and Cardiovascular Imaging Manifestations of Lupus.

Radiographics : a review publication of the Radiological Society of North America, Inc
2024

Sex-specific NLRP3 activation in neutrophils promotes neutrophil recruitment and NETosis in the murine model of diffuse alveolar hemorrhage.

Frontiers in immunology
2024

Elevation of NT-proBNP Levels in Pediatric and Young Adult Hematopoietic Stem Cell Transplant Patients with Endotheliopathy.

Pediatric reports
2024

Manifestations of Hydralazine-Induced Vasculitis: A Case Series.

Cureus
2024

Bronchoscopy in children with diffuse alveolar hemorrhage under general anesthesia with spontaneous respiration by face mask ventilation.

Medicine
2025

Trained mesenchymal stromal cell-based therapy HXB-319 for treating diffuse alveolar hemorrhage in a pristane-induced murine model.

Stem cells (Dayton, Ohio)
2024

Diffuse Alveolar Hemorrhage Due to Bupropion Inhalation.

Chest
2024

Occupational Diffuse Alveolar Hemorrhage Due to Metal Fume and Nitric Acid Exposure: A Case Report.

Cureus
2025

Diffuse alveolar hemorrhage: a retrospective study from a tertiary care center.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace
2024

Acute Respiratory Distress Syndrome After Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) Vaccination: Findings From an Autopsy.

Cureus
2024

High resolution computed tomography in systemic sclerosis: From diagnosis to follow-up.

Rheumatology and immunology research
2024

Critically Ill Patients with Newly Diagnosed Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Case Series and Literature Review.

Journal of clinical medicine
2024

Endovascular embolization of a congenital inferior phrenic artery-to-pulmonary arteriovenous malformation: a rare case report.

BMC pulmonary medicine
2024

Microscopic polyangiitis presenting as idiopathic pulmonary fibrosis.

Respiratory medicine case reports
2024

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in a Pediatric Patient Presenting With Hemoptysis.

Cureus
2024

Diffuse alveolar hemorrhage as the initial presentation of hypomorphic RAG1 deficiency.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2024

Seized by Blood: A Case of Neurogenic Pulmonary Edema Presenting As Diffuse Alveolar Hemorrhage.

Cureus
2024

A versatile role for lung ultrasound in systemic autoimmune rheumatic diseases related pulmonary involvement: a narrative review.

Arthritis research &amp; therapy
2024

Inhaled Anesthetic Sevoflurane-Associated Diffuse Alveolar Hemorrhage.

American journal of therapeutics
2024

Female With Hypertensive Emergency Later Found to Have ANCA-Associated Vasculitis: A Case Report.

Cureus
2024

Disseminated Varicella-Zoster Virus Presenting With Pneumonitis and Diffuse Alveolar Hemorrhage in an Immunocompetent Patient.

Cureus
2024

COVID-19-induced granulomatosis with polyangiitis: A case report of a 16-year-old East Asian and literature review.

Immunity, inflammation and disease
2024

Quantitative proteomic analysis and replacement therapy identifies haptoglobin as a therapeutic target in a murine model of SLE-associated diffuse alveolar hemorrhage.

Frontiers in veterinary science
2024

Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus: data from the Spanish society of rheumathology Lupus Register (RELESSER).

Rheumatology international
2024

Severe Granulomatosis With Polyangiitis Treated With Low-Dose Cyclophosphamide, Rituximab, Glucocorticoids, and Plasma Exchange: A Case Report.

Cureus
2024

A Case of Mitral Regurgitation Presenting as Diffuse Alveolar Hemorrhage.

The American journal of medicine
2024

Diffuse Alveolar Hemorrhage: A Rare Life-Threatening Cause of Massive Hemoptysis.

Cureus
2024

Diffuse alveolar hemorrhage in pediatrics: Etiologies and outcomes.

Pediatric pulmonology
2024

The Coexistence of Microscopic Polyangiitis and Rheumatoid Arthritis: A Case Report.

Cureus
2024

Pheochromocytoma-induced diffuse alveolar hemorrhage after cholecystectomy: A case report and literature review.

Heliyon
2024

Epidemiology of Diffuse Alveolar Hemorrhage in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients.

Transplantation and cellular therapy
2024

Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Diffuse Alveolar Hemorrhage With Avacopan.

ACR open rheumatology
2024

Successful treatment of diffuse alveolar hemorrhage secondary to Mycoplasma pneumoniae complicated with hemophagocytic lymphohistiocytosis in children: a case report and non-systematic literature review.

Frontiers in pediatrics
2024

Limited Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Presenting With Diffuse Alveolar Hemorrhage: A Case Report and Literature Review.

Cureus
2024

Analysis of BK Virus Infection in Children After Hematopoietic Cell Transplantation: A Retrospective Single-center Study.

Journal of pediatric hematology/oncology
2024

A Fatal Consequence: Amiodarone-Induced Multiorgan Toxicity.

Cureus
2024

An Aggressive Case of Cryoglobulinemia and Membranoproliferative Glomerulonephritis: A Case Report.

Cureus
2024

Organizing Pneumonia With Diffuse Alveolar Hemorrhage Induced by the Kampo Medicine Choreito.

Journal of medical cases
2024

Circulatory support with triple cannulation V-PaA ECMO in a patient with acute right ventricular failure and refractory hypoxemia secondary to diffuse alveolar hemorrhage: A case report.

Respiratory medicine case reports
2024

Granulomatosis With Polyangiitis: Cardiac, Renal, and Respiratory Involvement.

Cureus
2024

Pulmonary manifestations of VEXAS syndrome with acute interstitial pneumonia and diffuse alveolar hemorrhage: a case report and literature review.

ARP rheumatology
2024

Unilateral Alveolar Hemorrhage: A Rare Pulmonary Complication in Systemic Lupus Erythematosus.

Cureus
2024

Rapidly progressing pediatric Lupus with Diffuse Alveolar Hemorrhage and CNS involvement.

Clinical case reports
2024

A Rare Presentation of Systemic Lupus Erythematosus (SLE) With Hemoptysis and Hematuria: A Case Report.

Cureus
2024

MEK1/2- and ERK1/2-Mediated Lung Endothelial Injury and Altered Hemostasis Promote Diffuse Alveolar Hemorrhage in Murine Lupus.

Arthritis &amp; rheumatology (Hoboken, N.J.)
2024

Idiopathic pulmonary hemosiderosis associated with Kabuki syndrome.

Immunological medicine
2024

The Relentless Recurrence of Diffuse Alveolar Hemorrhage in Catastrophic Antiphospholipid Syndrome and Lupus: A Therapeutic Challenge.

Cureus
2024

Extensive Thrombosis in Catastrophic Antiphospholipid Syndrome in a Newly Diagnosed Systemic Lupus Erythematosus: A Case Report.

Cureus
2024

Effectiveness of Single-Fraction, Low-Dose, Bilateral Whole Lung Radiation Therapy for Diffuse Alveolar Hemorrhage Secondary to Extramedullary Hematopoiesis: A Case Report and Review of the Literature.

Advances in radiation oncology
2024

Antineutrophil cytoplasmic antibody-associated vasculitis.

Current opinion in nephrology and hypertension
2024

MEK1/2 and ERK1/2 mediated lung endothelial injury and altered hemostasis promote diffuse alveolar hemorrhage in murine lupus.

bioRxiv : the preprint server for biology
2025

Dupilumab-induced Diffuse Alveolar Hemorrhage.

Internal medicine (Tokyo, Japan)
2024

Early diagnosis of negative-pressure pulmonary edema presenting as diffuse alveolar hemorrhage using lung ultrasonography -A case report.

Anesthesia and pain medicine
2024

Pulmonary Manifestation of Granulomatosis With Polyangiitis: A Challenging Case Presentation.

Cureus
2024

Clinical characteristics, radiological features and outcomes in pulmonary involvement of cryoglobulinemia.

Orphanet journal of rare diseases
2024

Recurrent diffuse alveolar hemorrhage and extracorporeal membrane oxygenation utilization in a hematopoietic stem cell transplant patient with Hunter's syndrome.

Archive of clinical cases
2024

A Rare Presentation of Late-Onset Idiopathic Pulmonary Hemosiderosis: A Case Report.

Cureus
2024

Intrapulmonary administration of recombinant activated factor VII in pediatric, adolescent, and young adult oncology and hematopoietic cell transplant patients with pulmonary hemorrhage.

Frontiers in oncology
2024

Latent class analysis of chest CT abnormalities to define subphenotypes in patients with MPO-ANCA-positive microscopic polyangiitis.

Respiratory medicine
2024

Systemic Lupus Erythematosus-related Lung Disease.

Seminars in respiratory and critical care medicine
2024

Diffuse Alveolar Hemorrhage Caused by Disseminated Cryptococcosis in a Patient With Systemic Lupus Erythematosus.

Cureus
2024

Massive hemoptysis with end stage renal disease (ESRD): An initial symptom of rare disease.

Clinical case reports
2024

Rare case of cardiac angiosarcoma and alveolar hemorrhage in an adolescent patient initially suspected COVID19 infection: A case report and literature review.

Radiology case reports
2024

Pulmonary Renal Syndrome in ANCA-Negative Vasculitis.

Cureus
Ver todos os 755 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Hemorragia alveolar difusa.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Hemorragia alveolar difusa

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. A Bloody Cough and Clouded Lungs: Uncovering a Systemic Culprit in an Adolescent.
    Pediatrics· 2026· PMID 41713491mais citado
  2. Incidence and Impact of Endothelial Dysfunction Events and Veno-Occlusive Disease in Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide: A Retrospective Analysis From the Argentinian Group of Marrow Transplant and Cellular Therapy (GATMO-TC).
    Transplantation and cellular therapy· 2026· PMID 41520917mais citado
  3. Pulmonary hemorrhage as a first manifestation of Sj&#xf6;gren's disease in a young male adult.
    Folia medica· 2026· PMID 41879545mais citado
  4. Therapeutic Evolution and Outcomes in EGPA Complicated by Diffuse Alveolar Hemorrhage: case-based review.
    Modern rheumatology case reports· 2026· PMID 41879294mais citado
  5. Diffuse alveolar hemorrhage in systemic lupus erythematosus during the COVID-19 era-a retrospective analysis with mechanistic investigation.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi· 2026· PMID 41862393mais citado
  6. Cocaine-Levamisole-Associated Vasculopathy Mimicking ANCA-Associated Vasculitis and Presenting With Pulmonary-Renal Syndrome Requiring VV-ECMO Support.
    Am J Case Rep· 2026· PMID 41992585recente
  7. Management of anti-neutrophil cytoplasmic antibody-associated alveolar hemorrhage: A Bayesian reanalysis of the PEXIVAS trial.
    J Rheumatol· 2026· PMID 41985923recente
  8. Diffuse alveolar hemorrhage in rheumatic diseases: Clinical features, diagnosis, and management.
    Rheumatol Immunol Res· 2026· PMID 41969820recente
  9. When the airway closes: diffuse alveolar hemorrhage after foreign body aspiration.
    Medicina (B Aires)· 2026· PMID 41961624recente
  10. Pulmonary-renal Syndrome Caused by an Overlap Systemic Lupus Erythematosus/Antineutrophil Cytoplasmic Antibody-associated Vasculitis Syndrome in the Setting of Immune Complex-mediated Glomerulonephritis in a Patient with COVID-19 Infection.
    J Glob Infect Dis· 2026· PMID 41958486recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:90060(Orphanet)
  2. MONDO:0019540(MONDO)
  3. GARD:19110(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Q55788710(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Hemorragia alveolar difusa
Compêndio · Raras BR

Hemorragia alveolar difusa

ORPHA:90060 · MONDO:0019540
Prevalência
1-9 / 100 000
Herança
Not applicable
CID-10
R04.8 · Hemorragia de outras localizações das vias respiratórias
CID-11
Ensaios
1 ativos
Início
Adolescent, Adult, Childhood, Elderly, Infancy
Prevalência
1.0 (Europe)
MedGen
UMLS
C4476767
Repurposing
8 candidatos
adrenaloneadrenergic receptor agonist
carbazochromeoxytocin receptor agonist
carbetocinhemostatic agent
+5 outros
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades